Study Demonstrates Benefits Of MicroPulse Photocoagulation Over Current Standard Laser Treatment Of Diabetic Macular Edema
IRIDEX Corporation today announced that leading clinicians have performed and published the results of a new study* that compares the benefits of MicroPulse photocoagulation technology, similar to that used in the new generation IRIDEX lasers, over the standard-of-care protocol for the treatment of eyes with diabetic macular edema (DME). The results indicated that treating using MicroPulse mode was as effective as the standard-of-care protocol in treating DME but with the added advantages of causing no localized laser scars and significantly improving visual acuity. DME is damage to the retina caused (Read more...)